Cargando…

Thrombotic Thrombocytopenic Purpura and Gemcitabine

Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening complication of gemcitabine treatment. Since the approval of this nucleoside analog for the treatment of pancreatic cancer by the FDA in 1996, reported incidence varies from 0.015 to 1.4%. The classic ‘pentad’ describing the di...

Descripción completa

Detalles Bibliográficos
Autor principal: Kasi, Pashtoon Murtaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114619/
https://www.ncbi.nlm.nih.gov/pubmed/21691573
http://dx.doi.org/10.1159/000326801

Ejemplares similares